Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT05986591

Public ClinicalTrials.gov record NCT05986591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Crossover, Single Dose Study To Demonstrate Clinical Pharmacodynamic Bioequivalence of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Bioequivalence Study of Tiotropium Bromide Inhalation Powder 18 μg

Study identification

NCT ID
NCT05986591
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Xiromed LLC
Industry
Enrollment
335 participants

Conditions and interventions

Conditions

Interventions

Combination Product

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 17, 2022 (Actual)
Primary completion
Aug 11, 2023 (Actual)
Completion
Aug 14, 2023 (Actual)
Last update posted
Jan 31, 2024

2022 – 2023

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
22
Facility City State ZIP Site status
DownTown LA Research (West Coast) Los Angeles California 90017 —
Southwest General Heathcare Fort Myers Florida 33907 —
SIMED Health Gainesville Florida 32607 —
Clinical Research Solutions Kissimmee Florida 34744 —
Clintex Research Group, Inc. Miami Florida 33145 —
Research Institue of South Florida Miami Florida 33173 —
Vista Health Research Miami Florida 33176 —
Velocity Clinical Research - New Smyrna Beach New Smyrna Beach Florida 32132 —
Southern Clinical Research Zachary Louisiana 70791 —
Velocity clinical Research Syracuse (East North)) Syracuse New York 13057 —
Velocity Clinical Research-Cincinnati Cincinnati Ohio 45242 —
Velocity Clinical Research Grants Pass (W Coast) Grants Pass Oregon 97527 —
Velocity Clinical Research Medford Medford Oregon 97504 —
Greater Providence Clinical Research (East North) Cranston Rhode Island 02920 —
Velocity Clinical Research Anderson Anderson South Carolina 29621 —
Velocity Clinical Research Columbia Columbia South Carolina 29204 —
Velocity Clinical Research Gaffney Gaffney South Carolina 29340 —
Velocity Clinical Research Greenville Greenville South Carolina 29615 —
Velocity Clinical Research Spartanburg Spartanburg South Carolina 29303 —
Velocity Clinical Research Union Union South Carolina 29379 —
Inquest Clinical Research Cypress Texas 77433 —
Mt. Olympus Medical Research Houston Texas 77479 —
Sante Clinical Research Kerrville Texas 78028 —
Velocity Clinical Research-Utah West Jordan Utah 84088 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05986591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05986591 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →